Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Tumor Metabolism of Lung Cancer in Patients Who Underwent Percutaneous Radiation Measured With F-18-FDG-PET

This study has been completed.
Information provided by (Responsible Party):
Jörg Kotzerke, Dresden University of Technology Identifier:
First received: September 13, 2005
Last updated: August 23, 2011
Last verified: August 2011
The purpose of the study is to describe the regional and global FDG-kinetics in non-small-cell lung cancer (NSCLC) during percutaneous radiation therapy.

Lung Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Tumor Metabolism of Lung Cancer Underwent Percutaneous Radiation Measured With F-18-FDG-PET

Resource links provided by NLM:

Further study details as provided by Technische Universität Dresden:

Estimated Enrollment: 50
Study Start Date: July 2005

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
The study includes consecutive patients from Department of Radiooncology with inoperable non-small cell lung cancer (NSCLC) intended for a curative radiotherapy.

Inclusion Criteria:

  • Histologically confirmed NSCLC not curable by surgery
  • Karnofsky > 80%
  • Tumor volume and localization allow curative radiotherapy
  • Written consent

Exclusion Criteria:

  • Metastases
  • Diabetes
  • Pregnancy
  • Psychiatric impairment
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00180154

Department of Nuclear Medicine
Dresden, Germany, 01307
Sponsors and Collaborators
Technische Universität Dresden
Principal Investigator: Joerg Kotzerke, MD Department of Nuclear Medicine
  More Information

Responsible Party: Jörg Kotzerke, Prof. Dr., Dresden University of Technology Identifier: NCT00180154     History of Changes
Other Study ID Numbers: BCA-FDG-FU 
Study First Received: September 13, 2005
Last Updated: August 23, 2011
Health Authority: Germany: Federal Office for Radiation Protection

Keywords provided by Technische Universität Dresden:
radiation therapy

Additional relevant MeSH terms:
Lung Neoplasms
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Lung Diseases
Respiratory Tract Diseases
Fluorodeoxyglucose F18
Molecular Mechanisms of Pharmacological Action processed this record on October 25, 2016